AbbVie Inc (ABBV)

Index:

S&P 100

$ 229.57
   
  • Change Today:
    $2.70
  • 52 Week High: $244.38
  • 52 Week Low: $164.99
  • Currency: US Dollars
  • Shares Issued: 1,765.26m
  • Volume: 7,150,042
  • Market Cap: $405,250m
  • RiskGrade: 122
  • Beta: 0.44

Latest ShareCast News

AstraZeneca sells hypertension drug rights; Ends Allergan deal

By Frank Prenesti

Date: Monday 27 Jan 2020

(Sharecast News) - AstraZeneca said it had agreed to sell the global commercial rights to a range of hypertension treatments to Atnahs Pharma for up to $390m.

Botox maker Allergan reports jump in third-quarter revenues

By Abigail Townsend

Date: Tuesday 05 Nov 2019

(Sharecast News) - Botox maker Allergan, which is being taken over in a $63bn blockbuster deal, has upped its full-year guidance after posting a forecast-beating set of third-quarter numbers.

Abbvie snaps up Botox-maker Allergan in $63bn deal

By Iain Gilbert

Date: Tuesday 25 Jun 2019

(Sharecast News) - Chicago-based biopharmaceutical company Abbvie snapped up Botox-maker Allergan for roughly $63bn on Tuesday, mostly in cash.

Pharma firms to testify in Congress over drug pr... 26-Feb-2019 ShareCast
 
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AbbVie Inc Market Data

Currency US Dollars
Share Price $ 229.57
Change Today $ 2.70
% Change 1.19 %
52 Week High $244.38
52 Week Low $164.99
Volume 7,150,042
Shares Issued 1,765.26m
Market Cap $405,250m
Beta 0.44
RiskGrade 122

What The Brokers Say

Strong Buy 8
Buy 12
Neutral 9
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 17-Oct-2025

Time Volume / Share Price
15:59 100 @ $229.59
15:59 100 @ $229.59
15:59 195 @ $229.62
15:59 100 @ $229.59
15:59 100 @ $229.59

Top of Page